Experimental interventions that increasing FGF-1 expression can prevent high-fat-diet-induced obesity and insulin resistance and reduce fasting blood glucose and triglyceride levels by regulating lipolysis in adipose tissues and hepatic glucose production. The gene discussed is FGF1; the disease is Insulin resistance.